Cargando…

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

BACKGROUND AND AIMS: Teneligliptin was introduced in India in May 2015. It has gained popularity and is already widely prescribed in type 2 diabetes mellitus (T2DM). This “real life” data collection was conducted to assess the efficacy of teneligliptin in Indian T2DM patients. METHODS: Predesigned s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Sujoy, Trivedi, Shailesh, Sanyal, Debmalya, Modi, KD, Kharb, Sandeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108474/ https://www.ncbi.nlm.nih.gov/pubmed/27877058 http://dx.doi.org/10.2147/DMSO.S121770

Ejemplares similares

Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)
por: Ghosh, Sujoy, et al.
Publicado: (2020)

Efficacy and safety of teneligliptin
por: Singh, Awadhesh Kumar
Publicado: (2017)

Teneligliptin in management of type 2 diabetes mellitus
por: Sharma, Surendra Kumar, et al.
Publicado: (2016)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

ESICON 2012, Kolkata: The best of Indian Endocrinology
por: Sanyal, Debmalya, et al.
Publicado: (2012)

Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2022)

One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)
por: Kesavadev, Jothydev, et al.
Publicado: (2022)

Hyperthyroidism in children: treatment outcomes and preferences in Eastern India
por: Sanyal, Debmalya, et al.
Publicado: (2015)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
por: Seo, Da Hea, et al.
Publicado: (2021)

Presentation of gender dysphoria: A perspective from Eastern India
por: Sanyal, Debmalya, et al.
Publicado: (2016)

Juvenile Hypothyroidism: A Clinical Perspective from Eastern India
por: Raychaudhuri, Moutusi, et al.
Publicado: (2020)

A retrospective study evaluating efficacy and safety of linagliptin in treatment of NODAT (in renal transplant recipients) in a real world setting
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Pancreatic carcinoma in fibrocalcific pancreatic diabetes: An eastern India perspective
por: Chakraborty, Partha Pratim, et al.
Publicado: (2012)

Outcome and preferences in female-to-male subjects with gender dysphoria: Experience from Eastern India
por: Majumder, Anirban, et al.
Publicado: (2016)

Outcome and preferences in male–to–female subjects with gender dysphoria: Experience from Eastern India
por: Majumder, Anirban, et al.
Publicado: (2017)

An observational Prospective Study to Evaluate the Preoperative Risk Factors of New-onset Diabetes Mellitus after Renal Transplantation in a Tertiary Care Centre in Eastern India
por: Kumar, Santosh, et al.
Publicado: (2018)

Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
por: Sanyal, Debmalya, et al.
Publicado: (2017)

Efficacy of Digitally Supported and Real-Time Self-Monitoring of Blood Glucose-Driven Counseling in Patients with Type 2 Diabetes Mellitus: A Real-World, Retrospective Study in North India
por: Sabharwal, Mudit, et al.
Publicado: (2022)

Long-Term, Real-World Safety and Efficacy of Teneligliptin: A Post-Marketing Surveillance of More Than 10,000 Patients with Type 2 Diabetes in Japan
por: Kadowaki, Takashi, et al.
Publicado: (2019)

Endocrinology training in India
por: Bajaj, Sarita, et al.
Publicado: (2015)

Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study
por: Agarwal, Piyush, et al.
Publicado: (2018)

Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Xiaoxuan, et al.
Publicado: (2018)

Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes
por: Sanyal, Debmalya, et al.
Publicado: (2015)

Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance
por: Haneda, Masakazu, et al.
Publicado: (2018)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the North East India cohort of the A(1)chieve study
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Profile of Microvascular Disease in Type 2 Diabetes in a Tertiary Health Care Hospital in India
por: Kumar, Hari KVS, et al.
Publicado: (2012)

Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study
por: Borgharkar, Surendra S, et al.
Publicado: (2019)

Conducting real-world evidence studies in India
por: Bhatt, Arun
Publicado: (2019)

Baseline characteristics of participants in the LANDMARC trial: A 3‐year, pan‐india, prospective, longitudinal study to assess management and real‐world outcomes of diabetes mellitus
por: Das, Ashok K., et al.
Publicado: (2021)

Real-world perspective on career of pharmaceutical physicians in India: A working report (2018)
por: Lahiry, Sandeep, et al.
Publicado: (2020)

Clinical spectrum of hypopituitarism in India: A single center experience
por: Gundgurthi, Abhay, et al.
Publicado: (2012)

Teneligliptin and “Thorough QTc study”: thorough enough?
por: Ghosal, Samit
Publicado: (2019)

Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
por: Okuda, Yoshinori, et al.
Publicado: (2016)

Rationale, study design and methodology of the LANDMARC trial: a 3‐year, pan‐India, prospective, longitudinal study to assess management and real‐world outcomes of diabetes mellitus
por: Das, A. K., et al.
Publicado: (2019)

QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
por: Erande, S, et al.
Publicado: (2019)

Long‐term safety and efficacy of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes
por: Kadowaki, Takashi, et al.
Publicado: (2017)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
por: Han, Eugene, et al.
Publicado: (2020)

Legions of Presentations of Myxedema Coma: A Case Series from a Tertiary Hospital in India
por: Roy, Nirmalya, et al.
Publicado: (2020)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2fncd9neaabusqoijc5hj37m0j